Paediatric Consumer Health in Canada

Paediatric consumer health is set to see modest current value growth in Canada in 2024. Paediatric cough/cold remedies and paediatric analgesics are expected to see declining sales during the year as these categories continue to normalise after the massive spike in demand in 2022, which was caused by the flu/RSV/COVID “triple-demic” and led to shortages of such products. In 2024, most regions of Canada saw a return to more “normal” flu seasons compared to 2022, which served to lower demand.

The Paediatric Consumer Health in Canada report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Paediatric Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.